WCLC 2025 - Posters & ePosters-EP.12.63 Combining Chemotherapy With Osimertinib Beyond Progression in EGFR-Mutant NSCLC: A Case-Based Experiencecombining Chemotherapy and Osimertinib Beyond Progression in EGFR-Mutant NSCLC: A Case-Based Experience

EP.12.63 Combining Chemotherapy With Osimertinib Beyond Progression in EGFR-Mutant NSCLC: A Case-Based Experiencecombining Chemotherapy and Osimertinib Beyond Progression in EGFR-Mutant NSCLC: A Case-Based Experience

Back to course

Asset Subtitle

Ana Cardeña-Gutiérrez

Meta Tag

Speaker Ana Cardeña-Gutiérrez

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy